Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2014 by UNC Lineberger Comprehensive Cancer Center.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01305954
First received: February 17, 2011
Last updated: February 26, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)